Los puntos clave no están disponibles para este artículo en este momento.
HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from
Chen et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: